Suryeun Chung
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Suryeun Chung has a total of 76 co-authors. Here are the top co-authors by number of shared publications:
- Kiick Sung
Department of Thoracic and Cardiovascular Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea
11 shared publications - Yang Hyun Cho
Department of Thoracic and Cardiovascular Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea
11 shared publications - Wook Sung Kim
Department of Thoracic and Cardiovascular Surgery, Heart Vascular Stroke Institute, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea
10 shared publications - Dong Seop Jeong
Department of Thoracic and Cardiovascular Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea
8 shared publications - Ilkun Park
Department of Thoracic and Cardiovascular Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea
5 shared publications - Jun Ho Lee
Department of Thoracic and Cardiovascular Surgery, Korea University Anam Hospital, Korea University College of Medicine, Seoul 02841, Republic of Korea
5 shared publications
Latest Publications
- Open Access
- 28 April 2026
- Published by XMLink in Korean Circulation Journal
- Vol. 57
Clopidogrel Monotherapy in Patients With Chronic Coronary Syndrome Following Coronary Artery Bypass Grafting: A Nationwide Cohort Study.
The optimal antiplatelet strategy for secondary prevention in patients with chronic coronary syndrome (CCS) after coronary artery bypass grafting (CABG) remains controversial. We compared long-term clinical outcomes according to the antiplatelet strategy after CABG. A total of 29,898 patients with CCS who underwent CABG were identified from the Korean National Health Insurance Service database between January 2010 and December 2020. After applying exclusion criteria, the population was stratified based on antiplatelet use at discharge: dual antiplatelet therapy (DAPT, n=7,304), aspirin monotherapy (n=1,524), or clopidogrel monotherapy (n=218). The primary efficacy endpoint was major adverse cardiac and cerebrovascular events (MACCE), a composite of all-cause death, spontaneous myocardial infarction, and stroke up to 10 years. The primary safety endpoint was major bleeding requiring transfusion. The risk of MACCE was higher in the aspirin monotherapy group compared with DAPT at 10 years (39.9% vs. 47.7%, adjusted hazard ratio [HR], 1.16; 95% confidence interval [CI], 1.06-1.27). No significant difference was observed between DAPT and clopidogrel monotherapy (39.9% vs. 40.4%, adjusted HR, 1.05; 95% CI, 0.85-1.29). The risk of major bleeding requiring transfusion was lower with clopidogrel monotherapy than with DAPT (2.1% vs. 5.6%, adjusted HR, 0.36; 95% CI, 0.14-0.98), while rates were similar between DAPT and aspirin monotherapy (5.6% vs. 6.5%, adjusted HR, 1.06; 95% CI, 0.81-1.38). In patients with CCS undergoing CABG, clopidogrel monotherapy was associated with comparable ischemic outcomes and a lower risk of major bleeding compared with DAPT. Clopidogrel monotherapy may offer a favorable balance of efficacy and safety as an alternative to DAPT for secondary prevention in this population. ClinicalTrials.gov Identifier: NCT06881901.
- 28 April 2026
- Published by XMLink in Korean Circulation Journal
- Vol. 57
Open AccessClopidogrel Monotherapy in Patients With Chronic Coronary Syndrome Following Coronary Artery Bypass Grafting: A Nationwide Cohort Study.
The optimal antiplatelet strategy for secondary prevention in patients with chronic coronary syndrome (CCS) after coronary artery bypass grafting (CABG) remains controversial. We compared long-term clinical outcomes according to the antiplatelet strategy after CABG. A total of 29,898 patients with CCS who underwent CABG were identified from the Korean National Health Insurance Service database between January 2010 and December 2020. After applying exclusion criteria, the population was stratified based on antiplatelet use at discharge: dual antiplatelet therapy (DAPT, n=7,304), aspirin monotherapy (n=1,524), or clopidogrel monotherapy (n=218). The primary efficacy endpoint was major adverse cardiac and cerebrovascular events (MACCE), a composite of all-cause death, spontaneous myocardial infarction, and stroke up to 10 years. The primary safety endpoint was major bleeding requiring transfusion. The risk of MACCE was higher in the aspirin monotherapy group compared with DAPT at 10 years (39.9% vs. 47.7%, adjusted hazard ratio [HR], 1.16; 95% confidence interval [CI], 1.06-1.27). No significant difference was observed between DAPT and clopidogrel monotherapy (39.9% vs. 40.4%, adjusted HR, 1.05; 95% CI, 0.85-1.29). The risk of major bleeding requiring transfusion was lower with clopidogrel monotherapy than with DAPT (2.1% vs. 5.6%, adjusted HR, 0.36; 95% CI, 0.14-0.98), while rates were similar between DAPT and aspirin monotherapy (5.6% vs. 6.5%, adjusted HR, 1.06; 95% CI, 0.81-1.38). In patients with CCS undergoing CABG, clopidogrel monotherapy was associated with comparable ischemic outcomes and a lower risk of major bleeding compared with DAPT. Clopidogrel monotherapy may offer a favorable balance of efficacy and safety as an alternative to DAPT for secondary prevention in this population. ClinicalTrials.gov Identifier: NCT06881901.
- Open Access
- 8 February 2024
- Published by Korean Society for Thoracic and Cardiovascular Surgery in Journal of Chest Surgery
- Vol. 57  (4) , 413-417
Surgical Correction of Left Ventricular Assist Device Outflow Graft Obstruction Caused by a Wrapped Expanded Polytetrafluoroethylene Graft: A Case Report
Sung Min Kim, M.D., Ilkun Park, M.D., Siwon Oh, M.D., Hyo Won Seo, M.D., Ga Hee Jeong, M.D., Jun Ho Lee, M.D., Ph.D., Su Ryeun Chung, M.D., Ph.D., Kiick Sung, M.D., Ph.D., Wook Sung Kim, M.D., Ph.D., Yang Hyun Cho, M.D., Ph.D.. J Chest Surg 2024;57:413-7. https://doi.org/10.5090/jcs.23.133
- 8 February 2024
- Published by Korean Society for Thoracic and Cardiovascular Surgery in Journal of Chest Surgery
- Vol. 57  (4) , 413-417
Open AccessSurgical Correction of Left Ventricular Assist Device Outflow Graft Obstruction Caused by a Wrapped Expanded Polytetrafluoroethylene Graft: A Case Report
Sung Min Kim, M.D., Ilkun Park, M.D., Siwon Oh, M.D., Hyo Won Seo, M.D., Ga Hee Jeong, M.D., Jun Ho Lee, M.D., Ph.D., Su Ryeun Chung, M.D., Ph.D., Kiick Sung, M.D., Ph.D., Wook Sung Kim, M.D., Ph.D., Yang Hyun Cho, M.D., Ph.D.. J Chest Surg 2024;57:413-7. https://doi.org/10.5090/jcs.23.133
- Open Access
- 17 January 2024
- Published by Korean Society for Thoracic and Cardiovascular Surgery in Journal of Chest Surgery
- Vol. 57  (2) , 169-177
Pericardial Window Operation in Oncology Patients: Analysis of Long-Term Survival and Prognostic Factors
Sung Min Kim, M.D., Jun Ho Lee, M.D., Ph.D., Su Ryeun Chung, M.D, Ph.D., Kiick Sung, M.D., Ph.D., Wook Sung Kim, M.D., Ph.D., Yang Hyun Cho, M.D., Ph.D.. J Chest Surg 2024;57:169-77. https://doi.org/10.5090/jcs.23.113
- 17 January 2024
- Published by Korean Society for Thoracic and Cardiovascular Surgery in Journal of Chest Surgery
- Vol. 57  (2) , 169-177
Open AccessPericardial Window Operation in Oncology Patients: Analysis of Long-Term Survival and Prognostic Factors
Sung Min Kim, M.D., Jun Ho Lee, M.D., Ph.D., Su Ryeun Chung, M.D, Ph.D., Kiick Sung, M.D., Ph.D., Wook Sung Kim, M.D., Ph.D., Yang Hyun Cho, M.D., Ph.D.. J Chest Surg 2024;57:169-77. https://doi.org/10.5090/jcs.23.113
- Open Access
- 1 January 2024
- Published by XMLink in Journal of Korean Medical Science
- Vol. 39  (15) , e143
Outcomes of Concomitant Maze Procedure in Tricuspid Repair for Severe Tricuspid Regurgitation
Park I, et al. J Korean Med Sci. 2024 Apr;39(15):e143. https://doi.org/10.3346/jkms.2024.39.e143
- 1 January 2024
- Published by XMLink in Journal of Korean Medical Science
- Vol. 39  (15) , e143
Open AccessOutcomes of Concomitant Maze Procedure in Tricuspid Repair for Severe Tricuspid Regurgitation
Park I, et al. J Korean Med Sci. 2024 Apr;39(15):e143. https://doi.org/10.3346/jkms.2024.39.e143
- Open Access
- 16 February 2023
- Published by Korean Society for Thoracic and Cardiovascular Surgery in Journal of Chest Surgery
- Vol. 56  (3) , 197-203
Aortic Valve Replacement and Concomitant Multi-Vessel Coronary Artery Bypass: The Impact of Using the Bilateral Internal Thoracic Arteries on Early and Late Clinical Outcomes
Muhyung Heo, M.D., Myoung Young Kim, M.D., Jun Ho Lee, M.D., Ph.D., Suryeun Chung, M.D., Kiick Sung, M.D., Ph.D., Wook Sung Kim, M.D., Ph.D., Yang Hyun Cho, M.D., Ph.D.. J Chest Surg -0001;0:. https://doi.org/10.5090/jcs.22.122
- 16 February 2023
- Published by Korean Society for Thoracic and Cardiovascular Surgery in Journal of Chest Surgery
- Vol. 56  (3) , 197-203
Open AccessAortic Valve Replacement and Concomitant Multi-Vessel Coronary Artery Bypass: The Impact of Using the Bilateral Internal Thoracic Arteries on Early and Late Clinical Outcomes
Muhyung Heo, M.D., Myoung Young Kim, M.D., Jun Ho Lee, M.D., Ph.D., Suryeun Chung, M.D., Kiick Sung, M.D., Ph.D., Wook Sung Kim, M.D., Ph.D., Yang Hyun Cho, M.D., Ph.D.. J Chest Surg -0001;0:. https://doi.org/10.5090/jcs.22.122
- Open Access
- 16 February 2023
- Published by Korean Society for Thoracic and Cardiovascular Surgery in Journal of Chest Surgery
- Vol. 56  (3) , 224-227
HeartMate 3 Implantation via Only Left Thoracotomy: A Case Report
Mi Young Jang, M.D., Jun Ho Lee, M.D., Ph.D., Su Ryeun Chung, M.D., Ph.D., Kiick Sung, M.D., Ph.D., Wook Sung Kim, M.D., Ph.D., Yang Hyun Cho, M.D., Ph.D.. J Chest Surg -0001;0:. https://doi.org/10.5090/jcs.22.113
- 16 February 2023
- Published by Korean Society for Thoracic and Cardiovascular Surgery in Journal of Chest Surgery
- Vol. 56  (3) , 224-227
Open AccessHeartMate 3 Implantation via Only Left Thoracotomy: A Case Report
Mi Young Jang, M.D., Jun Ho Lee, M.D., Ph.D., Su Ryeun Chung, M.D., Ph.D., Kiick Sung, M.D., Ph.D., Wook Sung Kim, M.D., Ph.D., Yang Hyun Cho, M.D., Ph.D.. J Chest Surg -0001;0:. https://doi.org/10.5090/jcs.22.113
- Open Access
- 30 January 2023
- Published by Korean Society for Thoracic and Cardiovascular Surgery in Journal of Chest Surgery
- Vol. 56  (3) , 186-193
Impact of Interatrial Septal Reconstruction on Atrial Tachyarrhythmia after Surgical Resection of Myxoma
Mi Young Jang, M.D.*, Jun Ho Lee, M.D., Ph.D.*, Muhyung Heo, M.D., Suk Kyung Lim, M.D., Su Ryeun Chung, M.D., Ph.D., Kiick Sung, M.D., Ph.D., Wook Sung Kim, M.D., Ph.D., Yang Hyun Cho, M.D., Ph.D.. J Chest Surg -0001;0:. https://doi.org/10.5090/jcs.22.112
- 30 January 2023
- Published by Korean Society for Thoracic and Cardiovascular Surgery in Journal of Chest Surgery
- Vol. 56  (3) , 186-193
Open AccessImpact of Interatrial Septal Reconstruction on Atrial Tachyarrhythmia after Surgical Resection of Myxoma
Mi Young Jang, M.D.*, Jun Ho Lee, M.D., Ph.D.*, Muhyung Heo, M.D., Suk Kyung Lim, M.D., Su Ryeun Chung, M.D., Ph.D., Kiick Sung, M.D., Ph.D., Wook Sung Kim, M.D., Ph.D., Yang Hyun Cho, M.D., Ph.D.. J Chest Surg -0001;0:. https://doi.org/10.5090/jcs.22.112
- Open Access
- 30 January 2023
- Published by Korean Society for Thoracic and Cardiovascular Surgery in Journal of Chest Surgery
- Vol. 56  (2) , 90-98
Comparison of Early Complications of Oral Anticoagulants after Totally Thoracoscopic Ablation: Warfarin versus Non-vitamin K Antagonist Oral Anticoagulants
MuHyung Heo, M.D., Dong Seop Jeong, M.D., Ph.D., Suryeun Chung, M.D., Ph.D., Kyoung Min Park, M.D., Ph.D., Seung Jung Park, M.D., Ph.D., Young Keun On, M.D., Ph.D.. J Chest Surg -0001;0:. https://doi.org/10.5090/jcs.22.081
- 30 January 2023
- Published by Korean Society for Thoracic and Cardiovascular Surgery in Journal of Chest Surgery
- Vol. 56  (2) , 90-98
Open AccessComparison of Early Complications of Oral Anticoagulants after Totally Thoracoscopic Ablation: Warfarin versus Non-vitamin K Antagonist Oral Anticoagulants
MuHyung Heo, M.D., Dong Seop Jeong, M.D., Ph.D., Suryeun Chung, M.D., Ph.D., Kyoung Min Park, M.D., Ph.D., Seung Jung Park, M.D., Ph.D., Young Keun On, M.D., Ph.D.. J Chest Surg -0001;0:. https://doi.org/10.5090/jcs.22.081
- Open Access
- 1 January 2023
- Published by XMLink in Journal of Korean Medical Science
- Vol. 38  (39) , e320
Totally Thoracoscopic Ablation in Patients With Recurrent Atrial Fibrillation After Catheter Ablation
Lim SK, et al. J Korean Med Sci. 2023 Sep;38(39):e320. https://doi.org/10.3346/jkms.2023.38.e320
- 1 January 2023
- Published by XMLink in Journal of Korean Medical Science
- Vol. 38  (39) , e320
Open AccessTotally Thoracoscopic Ablation in Patients With Recurrent Atrial Fibrillation After Catheter Ablation
Lim SK, et al. J Korean Med Sci. 2023 Sep;38(39):e320. https://doi.org/10.3346/jkms.2023.38.e320
- Open Access
- 5 August 2022
- Published by Oxford University Press (OUP) in ESC Heart Failure
- Vol. 9  (6) , 3868-3875
Association of Longitudinal Left Atrial Strain with Mortality After Tricuspid Valve Surgery
Aims: Tricuspid valve (TV) surgery for functional tricuspid regurgitation (TR) is becoming more common, but the associated mortality remains high. Therefore, we evaluated the clinical and echocardiographic parameters associated with all-cause mortality in patients with severe functional TR who underwent TV surgery. Methods and results: A total of 286 patients with severe functional TR who underwent TV replacement or repair was analysed between January 2006 and December 2017. We assessed changes in conventional echocardiographic parameters and strain, such as peak atrial longitudinal strain (PALS). During a median follow-up period of 5.3 years, 71 (24.8%) patients died due to any cause. When comparing groups with and without all-cause deaths, there were no significant differences in terms of sex, co-morbidities, medication use, and surgery type. However, patients who died were older and more likely to have refractory atrial fibrillation (AF). With multivariate Cox modelling, age >65 years (adjusted hazard ratio [HR], 2.81, 95% confidence interval [CI], 1.59–4.96; P < 0.001), refractory AF (adjusted HR, 2.84, 95% CI, 1.36–5.94; P = 0.006), lower albumin level (adjusted HR, 0.50, 95% CI, 0.31–0.82), and reduced PALS (adjusted HR, 1.87, 95% CI, 1.06–3.33; P = 0.032) were significant determinants of all-cause mortality. PALS decline was associated with refractory AF (adjusted HR, 5.74, 95% CI, 2.81–11.7; P < 0.001) and the absence of a Maze procedure (adjusted HR, 2.95, 95% CI, 1.51–5.78; P = 0.002). Conclusions: A reduction in PALS was significantly associated with all-cause mortality in our cohort of patients with severe functional TR who underwent TV surgery. This phenomenon is related to refractory AF and more aggressive intervention for AF is necessary concomitant with TV surgery.
- 5 August 2022
- Published by Oxford University Press (OUP) in ESC Heart Failure
- Vol. 9  (6) , 3868-3875
Open AccessAssociation of Longitudinal Left Atrial Strain with Mortality After Tricuspid Valve Surgery
Aims: Tricuspid valve (TV) surgery for functional tricuspid regurgitation (TR) is becoming more common, but the associated mortality remains high. Therefore, we evaluated the clinical and echocardiographic parameters associated with all-cause mortality in patients with severe functional TR who underwent TV surgery. Methods and results: A total of 286 patients with severe functional TR who underwent TV replacement or repair was analysed between January 2006 and December 2017. We assessed changes in conventional echocardiographic parameters and strain, such as peak atrial longitudinal strain (PALS). During a median follow-up period of 5.3 years, 71 (24.8%) patients died due to any cause. When comparing groups with and without all-cause deaths, there were no significant differences in terms of sex, co-morbidities, medication use, and surgery type. However, patients who died were older and more likely to have refractory atrial fibrillation (AF). With multivariate Cox modelling, age >65 years (adjusted hazard ratio [HR], 2.81, 95% confidence interval [CI], 1.59–4.96; P < 0.001), refractory AF (adjusted HR, 2.84, 95% CI, 1.36–5.94; P = 0.006), lower albumin level (adjusted HR, 0.50, 95% CI, 0.31–0.82), and reduced PALS (adjusted HR, 1.87, 95% CI, 1.06–3.33; P = 0.032) were significant determinants of all-cause mortality. PALS decline was associated with refractory AF (adjusted HR, 5.74, 95% CI, 2.81–11.7; P < 0.001) and the absence of a Maze procedure (adjusted HR, 2.95, 95% CI, 1.51–5.78; P = 0.002). Conclusions: A reduction in PALS was significantly associated with all-cause mortality in our cohort of patients with severe functional TR who underwent TV surgery. This phenomenon is related to refractory AF and more aggressive intervention for AF is necessary concomitant with TV surgery.